Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K/A Current report
- 23.1 Consent of WWC, P.C
- 99.1 Audited Financial Statements of Aibl for the Period from January 10, 2023 Until September 30, 2023
- 99.2 Unaudited Pro Forma Condensed Combined Statement of Operations of the Company and Aibl As of and for the Nine Months Ended September 30, 2023
- Download Excel data file
- View Excel data file
ABVC similar filings
- 14 Mar 24 Amendments to Articles of Incorporation or Bylaws
- 14 Mar 24 ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
- 8 Feb 24 ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
- 26 Jan 24 Report of Independent Registered Public Accounting Firm
- 17 Jan 24 Submission of Matters to a Vote of Security Holders
- 17 Jan 24 Entry into a Material Definitive Agreement
- 20 Nov 23 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement on Form S-3 (File No. 333-260588), Registration Statement on Form S-8 (File No. 333-234656) of ABVC BioPharma, Inc. of our report dated January 25, 2024, relating to the financial statements of AIBTL BIOPHARMA INC., appearing in this Current Report on Form 8-K/A dated January 25, 2024.
/s/ WWC, P.C. | |
WWC, P.C. | |
January 25, 2024 |